← Back to headlines
Merck's Oral PCSK9 Enlicitide Demonstrates Superior Cholesterol Lowering
Merck's oral PCSK9 enlicitide has shown improved cholesterol-lowering capabilities when compared to non-statin treatments.
30 Mar, 18:54 — 30 Mar, 18:54
Sources
Showing 1 of 1 sources
Related Stories
Mayon Volcano Continues to Spew Lava Fountains in Philippines
just now
UN Conference Adds 40 Migratory Species, Including Snowy Owl, to Protection List
31m ago
Arsenic Levels Rising in Mekong River, Warn Civil Society Groups
44m ago
SpaceX Starlink Satellite Loses Contact, Poses No Threat to Artemis II Mission
46m ago